206A Share Price Performance
JP¥193.00
-2.00 (-1.03%)
Price JP¥193.00
Share Pricen/a
PRISM BioLab Co.,LTD Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
206A Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
PRISM BioLab Co.,LTD Key Details
Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
May 14, 2026
- -25.12
- 38.47%
- -135.52%
- 0%
About 206A
- Founded
- 2006
- Employees
- n/a
- CEO
- WebsiteView website
PRISM BioLab Co.,LTD engages in the research and development of pharmaceuticals using its proprietary drug discovery platform technology, PepMetics Technology. It develops E7386 targeting CBP/beta-catenin, which is in Phase II clinical trial for the treatment of cancer; and PRI724 targeting CBP/beta-catenin that is in Phase II clinical trial for treating cirrhosis. The company has a strategic collaboration with Receptor.AI Inc. for the development of an AI-integrated drug discovery platform. The company was founded in 2006 and is based in Fujisawa, treating Japan.
